tailieunhanh - Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer

KRAS is the most frequently mutated oncogene in cancer, however efforts to develop targeted therapies have been largely unsuccessful. Recently, two small-molecule inhibitors, AMG 510 and MRTX849, have shown promising activity in KRAS G12C-mutant solid tumors. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN